Just in time for the holidays – and the growing season – the U.S. Environmental Protection Agency (EPA) has granted new registrations for pesticides to be used on hemp crops, including, for the first time, hemp used in the production
Continue Reading Happy Hemp-days! EPA Grants First Ever Approvals for Pesticides Used on Hemp for Consumable CBD Products
Podcast: CBD Warning Letters, FDA Commissioner Confirmation Hearing and Preview of Upcoming Webinar
On the latest episode of the Ad Law Access Podcast, partner Kristi Wolff discusses FDA’s recent CBD warning letters, Commissioner nominee Dr. Stephen Hahn’s confirmation hearings, and a preview of this week’s Cannabis Law Update webinar.
On Thursday, December
Continue Reading Podcast: CBD Warning Letters, FDA Commissioner Confirmation Hearing and Preview of Upcoming Webinar
Joint Warning Letter Targets CBD Claims Relating To Infant and Child Uses
Any parent who has tried in vain to soothe a child suffering from a painful ear infection or comfort a teething baby knows that feeling of desperation when you may be willing to try just about anything to get the
Continue Reading Joint Warning Letter Targets CBD Claims Relating To Infant and Child Uses
New California Cannabis-Related Bills Make it Off the Governor’s Desk
On October 12, 2019, California Governor Gavin Newsom announced the following cannabis-related bills were signed into law:
- AB 37
- Allows cannabis businesses to claim state tax deductions and credits available to other legal businesses in the state for each taxable
Continue Reading New California Cannabis-Related Bills Make it Off the Governor’s Desk
Judge Denies CBD “No THC” Appeal; CBD False Advertising Lawsuits Continue
As we discussed previously, a truck driver and his wife brought suit in New York federal court against three companies selling a CBD oil product the trucker claims caused him to fail a drug test and thereby lose his
Continue Reading Judge Denies CBD “No THC” Appeal; CBD False Advertising Lawsuits Continue
Navigating the Haze of Cannabis Rules and Regulations in Europe
On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet
Continue Reading Navigating the Haze of Cannabis Rules and Regulations in Europe
FTC Issues Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases
Today, the FTC issued warning letters to three companies selling CBD products. The companies, which FTC did not identify publicly, allegedly illegally advertised CBD products as being able to treat or cure serious diseases and health conditions without competent and
Continue Reading FTC Issues Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases
Ninth Circuit Abstains From Case Involving Interstate Shipment of Hemp
On September 4, 2019, the Ninth Circuit Court of Appeals held that the lower court should have abstained from ruling in Big Sky Scientific LLC v. Idaho State Police and determined that Idaho state court provides a satisfactory venue for
Continue Reading Ninth Circuit Abstains From Case Involving Interstate Shipment of Hemp
In Suspense: California Hemp Bill Stalls
On August 30, 2019, the California Senate Appropriations Committee failed to move AB-228 out of the committee and instead held the bill on “Suspense” during its final hearing of the 2019 legislative session. As we have written previously, AB-228
Continue Reading In Suspense: California Hemp Bill Stalls
Kelley Drye’s CBD Update Webinar
Join Kelley Drye’s Cannabis Law practice group, including partners Kristi Wolff and Laura van der Meer, and guest speaker Megan Olsen from the Council for Responsible Nutrition, for a detailed look at several relevant CBD topics; including the
Continue Reading Kelley Drye’s CBD Update Webinar